Valuation of the EORTC Quality of Life Utility Core 10 Dimensions (QLU-C10D) in a Multi-ethnic Asian Setting: How Does Having Cancer Matter?

被引:0
|
作者
Gandhi, Mihir [1 ,2 ,3 ,4 ]
Kanesvaran, Ravindran [5 ]
Rashid, Mohamad Farid Bin Harunal [5 ]
Chong, Dawn Qingqing [5 ]
Chay, Wen-Yee [5 ]
Tan, Rachel Lee-Yin [6 ]
Norman, Richard [7 ]
King, Madeleine T. [8 ]
Luo, Nan [6 ]
机构
[1] Consortium Clin Res & Innovat Singapore, Singapore Clin Res Inst, Biostat, Singapore, Singapore
[2] Duke NUS, Ctr Quantitat Med, Med Sch, Singapore, Singapore
[3] Duke NUS, Lien Ctr Palliat Care, Med Sch, Singapore, Singapore
[4] Tampere Univ, Tampere Ctr Child Adolescent & Maternal Hlth Res, Global Hlth Grp, Tampere, Finland
[5] Natl Canc Ctr Singapore, Div Med Oncol, Singapore, Singapore
[6] Natl Univ Singapore, Saw Swee Hock Sch Publ Hlth, Singapore, Singapore
[7] Curtin Univ, Sch Populat Hlth, Perth, Australia
[8] Univ Sydney, Sch Psychol, Sydney, Australia
基金
英国医学研究理事会;
关键词
GENERAL-POPULATION; EUROPEAN-ORGANIZATION; STATED PREFERENCES; COST-EFFECTIVENESS; CLINICAL-TRIALS; PATIENT; QUESTIONNAIRE; INSTRUMENT; OUTCOMES; ENGLISH;
D O I
10.1007/s40273-024-01432-5
中图分类号
F [经济];
学科分类号
02 ;
摘要
ObjectivesThe aim of the study was to develop and compare utility value sets for the EORTC QLU-C10D, a cancer-specific utility instrument based on the EORTC QLQ-C30, using the preferences of the general public and cancer patients in Singapore, and to assess their measurement properties.MethodsA total of 600 individuals from the general public were recruited using a multi-stage random sampling, along with 626 cancer patients with clinically confirmed diagnoses from outpatient clinics of the largest tertiary cancer hospital. Each participant valued 16 pairs of EORTC QLU-C10D health states using a discrete choice experiment (DCE). Conditional logit models were used to analyze the DCE responses of the general public and cancer patients separately. Utility values were assessed for known-group validity and responsiveness in the cancer patients by comparing mean values across subgroups of patients and calculating standardized response means using longitudinal EORTC QLQ-C30 data, respectively.ResultsPhysical functioning and pain had the most impact on utility for both cancer patients and general public groups. Worst health state utility values were -0.821 and -0.463 for the general public and cancer patients, respectively. Cancer patients' values were lower for mild-to-moderate health states but higher for moderately-to-highly impaired states compared with the general public's values. Both value sets discriminated between patients with differing characteristics and responded equally well to improved health status, but the cancer patients' value set was slightly more responsive to deteriorated health.ConclusionsEORTC QLU-C10D value sets based on the preferences of the Singaporean general public and cancer patients exhibited differences in values but similar psychometric properties.
引用
收藏
页码:1413 / 1425
页数:13
相关论文
共 29 条
  • [21] Cancer-specific utility instrument for health economic evaluations: A synopsis of the EORTC QLU-C10D user manual and current validity evidence
    Seyringer, Simone
    Pilz, Micha Johannes
    Jansen, Femke
    Buettner, Matthias
    King, Madeleine T.
    Norman, Richard
    Kemmler, Georg
    Nerich, Virginie
    Holzner, Bernhard
    Bottomley, Andrew
    Gamper, Eva M.
    EUROPEAN JOURNAL OF CANCER, 2025, 217
  • [22] Assessing health-related quality of life in cancer survivors: factors impacting on EORTC QLU-C10D-derived utility values
    Thomas van Gelder
    Brendan Mulhern
    Dounya Schoormans
    Olga Husson
    Richard De Abreu Lourenço
    Quality of Life Research, 2020, 29 : 1483 - 1494
  • [23] The EORTC QLU-C10D is a valid cancer-specific preference-based measure for cost-utility and health technology assessment in the Netherlands
    Pilz, Micha J.
    Seyringer, Simon
    Hallsson, Lara R.
    Bottomley, Andrew
    Jansen, Femke
    King, Madeleine T.
    Norman, Richard
    Rutten, Marianne J.
    Verdonck-de Leeuw, Irma M.
    Siersema, Peter D.
    Gamper, Eva Maria
    EUROPEAN JOURNAL OF HEALTH ECONOMICS, 2024, 25 (09): : 1539 - 1555
  • [24] Assessing health-related quality of life in cancer survivors: factors impacting on EORTC QLU-C10D-derived utility values
    van Gelder, Thomas
    Mulhern, Brendan
    Schoormans, Dounya
    Husson, Olga
    Lourenco, Richard de Abreu
    QUALITY OF LIFE RESEARCH, 2020, 29 (06) : 1483 - 1494
  • [25] Validation of the cancer-specific utility measure EORTC QLU-C10D using evidence from four lung cancer trials covering six country value sets
    Simone Seyringer
    Micha J. Pilz
    Imad Al-Naesan
    Madeleine T. King
    Andrew Bottomley
    Richard Norman
    Lisa Schlosser
    Tobias Hell
    Eva M. Gamper
    Scientific Reports, 15 (1)
  • [26] QLU-C10D: a health state classification system for a multi-attribute utility measure based on the EORTC QLQ-C30 (vol 25, pg 625, 2016)
    King, M. T.
    Costa, D. S. J.
    Aaronson, N. K.
    Brazier, J. E.
    Cella, D. F.
    Fayers, P. M.
    Grimison, P.
    Janda, M.
    Kemmler, G.
    Norman, R.
    Pickard, A. S.
    Rowen, D.
    Velikova, G.
    Young, T. A.
    Viney, R.
    QUALITY OF LIFE RESEARCH, 2016, 25 (10) : 2683 - 2683
  • [27] Cancer-specific utility instrument for health economic evaluations: A synopsis of the EORTC QLU-C10D user manual and current validity evidence ( vol 217 , 115235 , 2025)
    Seyringer, Simone
    Pilz, Micha
    Jansen, Femke
    Buettner, Matthias
    King, Madeleine T.
    Norman, Richard
    Kemmler, Georg
    Nerich, Virginie
    Holzner, Bernhard
    Bottomley, Andrew
    Gamper, Eva M.
    EUROPEAN JOURNAL OF CANCER, 2025, 219
  • [28] Cancer-Specific Health Utilities: Evaluation of Core Measurement Properties of the EORTC QLU-C10D in Lung Cancer Patients-Data from Four Multicentre LUX-Lung Trials, Applying Six Country Tariffs
    Pilz, Micha J.
    Seyringer, Simone
    Al-Naesan, Imad
    King, Madeleine T.
    Bottomley, Andrew
    Norman, Richard
    Schlosser, Lisa
    Hell, Tobias
    Gamper, Eva Maria
    PHARMACOECONOMICS-OPEN, 2024, 8 (04) : 627 - 640
  • [29] A Comparison of Generic and Condition-Specific Preference-Based Measures Using Data From Nivolumab Trials: EQ-5D-3L, Mapping to the EQ-5D-5L, and European Organisation for Research and Treatment of Cancer Quality of Life Utility Measure-Core 10 Dimensions
    Shaw, James W.
    Bennett, Bryan
    Trigg, Andrew
    DeRosa, Michael
    Taylor, Fiona
    Kiff, Christopher
    Ntais, Dionysios
    Noon, Katie
    King, Madeleine T.
    Cocks, Kim
    VALUE IN HEALTH, 2021, 24 (11) : 1651 - 1659